Table 2.
Evaluation of potential risk factors for capsular incision (n=233)
| Variables | P-value | Odds ratio | 95% CI | |
|---|---|---|---|---|
| Univariate | Multivariate | |||
| Pre-operative PSA (ng ml–1) | ||||
| <10 | 0.065 | Reference | ||
| ⩾10 | 0.122 | 1.986 | 0.832–4.741 | |
| Gleason score at biopsy specimen | ||||
| ⩽6 | 0.927 | Reference | ||
| 7 | 0.459 | 0.717 | 0.297–1.731 | |
| ⩾8 | 0.446 | 0.647 | 0.212–1.979 | |
| Prostate volume (ml) | 0.023 | 0.083 | 0.973 | 0.942–1.004 |
| Nerve-sparing procedure | ||||
| No | 0.036 | Reference | ||
| Yes | 0.173 | 0.530 | 0.213–1.321 | |
| % of positive core at biopsy | ||||
| ⩽25% | 0.014 | Reference | ||
| >25% | 0.039 | 2.333 | 1.045–5.211 | |
| Number of surgery experienced | 0.016 | 0.018 | 0.398 | 0.185–0.856 |
Abbreviations: CI, Confidence interval; PSA, prostate-specific antigen.